- No file added yet -

Real-World Tumor Response of Palbociclib Plus Letrozole Versus Letrozole for Metastatic Breast Cancer in US Clinical Practice

Version 2 2021-09-30, 09:17

Version 1 2021-07-21, 10:17

media

posted on 2021-09-30, 09:17 authored by Adam M. Brufsky, Xianchen Liu, Benjamin Li, Lynn McRoy, Rachel M. Layman

Article full text

The above video abstract represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

History

Usage metrics

Keywords

Breast Cancer Palbociclib CDK4/6 pathway CDK inhibitor

Licence

CC BY 4.0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM